vs
Datavault AI Inc.(DVLT)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Datavault AI Inc.的1.1倍($35.5M vs $33.8M),Datavault AI Inc.净利率更高(2.0% vs -304.2%,领先306.2%),Datavault AI Inc.同比增速更快(3649.6% vs 681.7%),Datavault AI Inc.自由现金流更多($-734.0K vs $-47.3M),过去两年Datavault AI Inc.的营收复合增速更高(1051.7% vs 60.5%)
Datavault AI Inc是一家人工智能科技企业,主打AI驱动的数据管理与集成解决方案,主要服务北美地区的企业客户,帮助客户整合分散数据资产,优化分析流程,加速机器学习模型的开发与落地。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
DVLT vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.1倍
$33.8M
营收增速更快
DVLT
高出2967.8%
681.7%
净利率更高
DVLT
高出306.2%
-304.2%
自由现金流更多
DVLT
多$46.6M
$-47.3M
两年增速更快
DVLT
近两年复合增速
60.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $33.8M | $35.5M |
| 净利润 | $661.0K | $-108.1M |
| 毛利率 | 89.3% | 59.8% |
| 营业利润率 | 12.3% | -304.8% |
| 净利率 | 2.0% | -304.2% |
| 营收同比 | 3649.6% | 681.7% |
| 净利润同比 | 110.4% | 39.6% |
| 每股收益(稀释后) | $0.53 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DVLT
RXRX
| Q4 25 | $33.8M | $35.5M | ||
| Q3 25 | $2.9M | $5.2M | ||
| Q2 25 | $1.7M | $19.2M | ||
| Q1 25 | $629.0K | $14.7M | ||
| Q4 24 | $902.0K | $4.5M | ||
| Q3 24 | $1.2M | $26.1M | ||
| Q2 24 | $345.0K | $14.4M | ||
| Q1 24 | $255.0K | $13.8M |
净利润
DVLT
RXRX
| Q4 25 | $661.0K | $-108.1M | ||
| Q3 25 | $-33.0M | $-162.3M | ||
| Q2 25 | $-37.1M | $-171.9M | ||
| Q1 25 | $-9.6M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $-5.1M | $-95.8M | ||
| Q2 24 | $-42.7M | $-97.5M | ||
| Q1 24 | $2.7M | $-91.4M |
毛利率
DVLT
RXRX
| Q4 25 | 89.3% | 59.8% | ||
| Q3 25 | 3.3% | -183.8% | ||
| Q2 25 | 2.0% | -4.9% | ||
| Q1 25 | 11.0% | -48.0% | ||
| Q4 24 | 24.6% | -181.4% | ||
| Q3 24 | 19.3% | 53.7% | ||
| Q2 24 | 3.2% | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率
DVLT
RXRX
| Q4 25 | 12.3% | -304.8% | ||
| Q3 25 | -508.1% | -3327.6% | ||
| Q2 25 | -718.1% | -916.8% | ||
| Q1 25 | -1499.4% | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | -447.4% | -377.1% | ||
| Q2 24 | -1566.7% | -697.4% | ||
| Q1 24 | -1630.6% | -698.4% |
净利率
DVLT
RXRX
| Q4 25 | 2.0% | -304.2% | ||
| Q3 25 | -1135.5% | -3135.3% | ||
| Q2 25 | -2139.3% | -894.2% | ||
| Q1 25 | -1520.3% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | -434.5% | -367.5% | ||
| Q2 24 | -12366.7% | -676.6% | ||
| Q1 24 | 1061.6% | -662.4% |
每股收益(稀释后)
DVLT
RXRX
| Q4 25 | $0.53 | $-0.17 | ||
| Q3 25 | $-0.33 | $-0.36 | ||
| Q2 25 | $-0.54 | $-0.41 | ||
| Q1 25 | $-0.18 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | $-1.39 | $-0.34 | ||
| Q2 24 | $-11.89 | $-0.40 | ||
| Q1 24 | $-5.35 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $238.0M | $1.1B |
| 总资产 | $274.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
DVLT
RXRX
| Q4 25 | $2.0M | $743.3M | ||
| Q3 25 | $1.7M | $659.8M | ||
| Q2 25 | $662.0K | $525.1M | ||
| Q1 25 | $171.0K | $500.5M | ||
| Q4 24 | $3.3M | $594.4M | ||
| Q3 24 | $3.9M | $427.6M | ||
| Q2 24 | $6.1M | $474.3M | ||
| Q1 24 | $2.8M | $296.3M |
总债务
DVLT
RXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益
DVLT
RXRX
| Q4 25 | $238.0M | $1.1B | ||
| Q3 25 | $99.5M | $1.0B | ||
| Q2 25 | $74.1M | $919.1M | ||
| Q1 25 | $81.7M | $933.9M | ||
| Q4 24 | $85.7M | $1.0B | ||
| Q3 24 | $4.3M | $524.6M | ||
| Q2 24 | $6.4M | $584.4M | ||
| Q1 24 | $-2.7M | $401.2M |
总资产
DVLT
RXRX
| Q4 25 | $274.7M | $1.5B | ||
| Q3 25 | $138.7M | $1.4B | ||
| Q2 25 | $120.7M | $1.3B | ||
| Q1 25 | $95.7M | $1.3B | ||
| Q4 24 | $100.6M | $1.4B | ||
| Q3 24 | $8.0M | $726.5M | ||
| Q2 24 | $10.6M | $775.9M | ||
| Q1 24 | $6.9M | $557.8M |
负债/权益比
DVLT
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-406.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-734.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -2.2% | -133.1% |
| 资本支出强度资本支出/营收 | 1.0% | 3.5% |
| 现金转化率经营现金流/净利润 | -0.61× | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
DVLT
RXRX
| Q4 25 | $-406.0K | $-46.1M | ||
| Q3 25 | $-10.4M | $-117.4M | ||
| Q2 25 | $-6.8M | $-76.4M | ||
| Q1 25 | $-6.0M | $-132.0M | ||
| Q4 24 | $-17.5M | $-115.4M | ||
| Q3 24 | $-4.2M | $-59.2M | ||
| Q2 24 | $-5.5M | $-82.2M | ||
| Q1 24 | $-3.5M | $-102.3M |
自由现金流
DVLT
RXRX
| Q4 25 | $-734.0K | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | $-6.1M | $-133.8M | ||
| Q4 24 | $-17.6M | $-116.7M | ||
| Q3 24 | $-4.2M | $-63.8M | ||
| Q2 24 | $-5.5M | $-83.4M | ||
| Q1 24 | $-3.5M | $-109.0M |
自由现金流率
DVLT
RXRX
| Q4 25 | -2.2% | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | -966.0% | -907.4% | ||
| Q4 24 | -1946.9% | -2567.7% | ||
| Q3 24 | -361.7% | -244.6% | ||
| Q2 24 | -1599.7% | -578.5% | ||
| Q1 24 | -1390.6% | -789.9% |
资本支出强度
DVLT
RXRX
| Q4 25 | 1.0% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 8.3% | 12.4% | ||
| Q4 24 | 3.9% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 4.1% | 8.2% | ||
| Q1 24 | 2.4% | 48.2% |
现金转化率
DVLT
RXRX
| Q4 25 | -0.61× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.31× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVLT
| Eos Technology Holdings Inc. | $30.0M | 89% |
| Consumer Audio Products Components And Other Revenue Net | $3.2M | 9% |
RXRX
暂无分部数据